相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
- 英文名:
ISAHA
- 库存:
货期:询盘
- 供应商:
MedChemExpress LLC
- CAS号:
1219807-87-0
- 规格:
50 mg
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
4-Iodo-SAHA
CAS No. : 1219807-87-0
MCE 国际站:4-Iodo-SAHA
产品活性:4-Iodo-SAHA (1k) 是一种 I 类和 II 类 histone deacetylase (HDAC) 的抑制剂,对 Skbr3、HT29、U937、JA16 和 HL60 细胞的 EC50 值分别为 1.1、0.95、0.12、0.24、0.85 和 1.3 μM。4-Iodo-SAHA 可用于癌症的研究。
研究领域:Cell Cycle/DNA Damage | Epigenetics
作用靶点:HDAC
In Vitro: 4-Iodo-SAHA (0.1-100 μM; 48 h) inhibits Skbr3, HT29, U937, JA16 and HL60 cell lines .
4-Iodo-SAHA (2 μM; 6-24 h) affects acetylated H4 and p21 levels in SKBR3 cells.
In Vivo: 4-Iodo-SAHA (1k) (50 mg/kg; p.o. five times a week for two weeks) compares to SAHA-treated and control mice with similar toxicity.
相关产品:Trichostatin A | Vorinostat | 4-Phenylbutyric acid | Valproic acid | Sulforaphane | Panobinostat | Entinostat | Romidepsin | Tucidinostat | RGFP966 | Belinostat | Ricolinostat | Tubastatin A | TMP195 | Theophylline | Carbamazepine | Mocetinostat | Santacruzamate A | ITSA-1 | TMP269 | Tasquinimod | Fimepinostat | Tubacin | LMK-235 | Quisinostat | PCI-34051 | FT895
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验2: Preparation of 7‐IODO‐7‐Deazapurine Nucleosides Related to 2′‐Deoxyguanosine and 2′‐Deoxyxanthosine Basic Protocol 3: Preparation of 7‐Bromo‐7‐Deaza‐2′‐Deoxyisoguanosine Basic Protocol 4: Determination of pKa Values
一、实验原理 在DNA复制过程中,核苷的类似物5-溴脱氧尿嘧啶核苷(5-Bromodeoxyuridine简称BrdUrd)或5-碘尿嘧啶核苷(5-Iodo-2′-deoxyuridine简称IdUrd)可以代替核苷酸掺入新合成的DNA链,并占有胸腺嘧啶(Thymidine,T)的位置。哺乳类细胞在含有适当浓度的BrdUrd的培养液中经历二个分裂周期之后,其中期染色体的两个单体的DNA双链在化学组成上就有了差别:即一条染色单体的两股DNA的T位完全由BrdUrd代替,而另一条染色
Attachment of Nitroxide Spin Labels to Nucleic Acids for EPR
. First, the appropriate building blocks, either 5?iodo?substituted pyrimidine deoxy? or ribo?nucleoside phosphoramidites are prepared and incorporated by solid?phase synthesis. Following this, the protected oligonucleotides are ?on column? reacted with the acetylenic
技术资料暂无技术资料 索取技术资料

















